ClassID:

94559

C07D243/12 - CPC Classification

Classification description:

Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems 1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines

Recent Application in this class:
#1
20240417379
2024-12-19

P2X4 RECEPTOR ANTAGONIST

#2
20240376059
2024-11-14

Compounds for the Treatment of Alzheimer's Disease

#3
20230113588
2023-04-13

METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAMS) AND USES THEREOF

#4
20220380322
2022-12-01

P2X4 receptor antagonist

#5
20220273803
2022-09-01

CHOLECYSTOKININ B RECEPTOR TARGETING FOR IMAGING AND THERAPY

#6
20220119356
2022-04-21

Compounds for the treatment of Alzheimer's disease

#7
20210163490
2021-06-03

PERIPHERALLY RESTRICTED GABA POSITIVE ALLOSTERIC MODULATORS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME AND OTHER AILMENTS OF THE PERIPHERAL NERVOUS SYSTEM

#8
20200384114
2020-12-10

Cholecystokinin B receptor targeting for imaging and therapy

#9
20200347021
2020-11-05

Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

#10
20200281951
2020-09-10

Methods of treating anxiety by administering a substituted quinolone

#11
20200223806
2020-07-16

P2X4 receptor antagonist

#12
20200199083
2020-06-25

4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides

#13
20200181155
2020-06-11

Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system

#14
20200062759
2020-02-27

Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system

#15
20190142852
2019-05-16

Method of treating disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine

#16
20190076538
2019-03-14

Cholecystokinin B receptor targeting for imaging and therapy

#17
20190016715
2019-01-17

Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

#18
20180362543
2018-12-20

HIV REPLICATION INHIBITOR

#19
20180318314
2018-11-08

ANTITUMOR AGENT

#20
20180228909
2018-08-16

CCK2R-drug conjugates

#21
20180201587
2018-07-19

P2X4 receptor antagonist

#22
20180120306
2018-05-03

Haptens, hapten conjugates, compositions thereof and method for their preparation and use

#23
20180065939
2018-03-08

Process for the preparation of clobazam and its intermediate

#24
20180022693
2018-01-25

Enamine compounds for absorbance of electromagnetic energy

#25
20170312292
2017-11-02

Therapeutic compounds and uses thereof

#26
20170233386
2017-08-17

Compounds Which Have a Protective Activity with Respect to the Action of Toxins and of Viruses with an Intracellular Mode of Action

#27
20170217951
2017-08-03

Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof

#28
20170197967
2017-07-13

Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system

#29
20160280667
2016-09-29

P2X4 receptor antagonist

#30
20160272596
2016-09-22

Tetrahydro-benzodiazepinones

#31
20160024055
2016-01-28

Dimeric compounds

#32
20150252009
2015-09-10

Benzodiazepine derivative and method of producing the same

#33
20150141410
2015-05-21

GPR17 receptor modulators

#34
20150050212
2015-02-19

Cholecystokinin B receptor targeting for imaging and therapy

#35
20150038495
2015-02-05

THERAPEUTIC AGENT FOR PAIN

#36
20150025064
2015-01-22

Benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof

#37
20140357858
2014-12-04

P2X4 receptor antagonist

#38
20140343278
2014-11-20

Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation

#39
20140194621
2014-07-10

Process for producing benzo [b] [1,4] diazepine-2,4-dione compound

#40
20140073633
2014-03-13

Inhibitors of the shiga toxins trafficking through the retrograde pathway

#41
20130261081
2013-10-03

Substituted quinoxalines compounds

#42
20130172550
2013-07-04

P2Xreceptor antagonist

#43
20130150350
2013-06-13

Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication

#44
20120283249
2012-11-08

Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action

#45
20120238749
2012-09-20

INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME

#46
20120225866
2012-09-06

Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation

#47
20120189614
2012-07-26

Inhibitors of filovirus entry into host cells

#48
20120165319
2012-06-28

INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME

#49
20120149899
2012-06-14

Process for producing benzo[B][1,4]diazepine-2,4-dione compound

#50
20120010401
2012-01-12

METHOD FOR MANUFACTURING 1,5-BENZODIAZEPINE DERIVATIVE

#51
20110319396
2011-12-29

BENZODIAZEPIN-2-ON DERIVATIVES

#52
20110201601
2011-08-18

Inhibitors of the Shiga toxins trafficking through the retrograde pathway

#53
20110178069
2011-07-21

Inhibitors of interleukin-1β converting enzyme

#54
20110059956
2011-03-10

THERAPEUTIC AGENT FOR PAIN

#55
20110015371
2011-01-20

Inhibitors of interleukin-1 beta converting enzyme

#56
20100317619
2010-12-16

Selective agents for pain suppression

#57
20100297725
2010-11-25

Haptens, hapten conjugates, compositions thereof and method for their preparation and use

#58
20100184087
2010-07-22

Haptens, hapten conjugates, compositions thereof and method for their preparation and use

#59
20100144793
2010-06-10

NOVEL COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS

#60
20100143366
2010-06-10

ANTITUMOR AGENT

#61
20100130481
2010-05-27

ANTICONVULSANT AND ANXIOLYTIC METHODS OF USING RECEPTOR SUBTYPE SELECTIVE AGENTS

#62
20100086553
2010-04-08

ANTITUMOR AGENT

#63
20100069373
2010-03-18

SUBSTITUTED LACTAMS AS INHIBITORS OF A BETA PROTEIN PRODUCTION

#64
20100056501
2010-03-04

SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION

#65
20100048541
2010-02-25

SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION

#66
20100009966
2010-01-14

SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION

#67
20090170831
2009-07-02

Substituted lactams as inhibitors of Aβ protein production

#68
20090075971
2009-03-19

Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same

#69
20090069293
2009-03-12

SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF AB PROTEIN PRODUCTION

#70
20080305169
2008-12-11

Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds

#71
20080268462
2008-10-30

Haptens, hapten conjugates, compositions thereof and method for their preparation and use

#72
20080221087
2008-09-11

Substituted lactams as inhibitors of Aβ protein production

#73
20080207602
2008-08-28

Succinoylamino benzodiazepines as inhibitors of aβ protein production

#74
20080171735
2008-07-17

SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Abeta PROTEIN PRODUCTION

#75
20080161293
2008-07-03

Antitumor Agent

#76
20080108605
2008-05-08

ANXIOLYTIC AGENTS WITH REDUCED SEDATIVE AND ATAXIC EFFECTS

#77
20080103133
2008-05-01

4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives

#78
20080103128
2008-05-01

Lactams substituted by cyclic succinates as inhibitors of Aβ protein production

#79
20080085891
2008-04-10

Asthma and allergic inflammation modulators

#80
20080076760
2008-03-27

2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION

#81
20080070953
2008-03-20

Inhibitors of interleukin-1β converting enzyme

#82
20080039449
2008-02-14

Inhibitors of interleukin-1β converting enzyme

#83
20080027038
2008-01-31

N-Acylated lipophilic amino acid derivatives

#84
20070299058
2007-12-27

Anxiolytic Agents With Reduced Sedative And Ataxic Effects

#85
20070173491
2007-07-26

Substituted lactams as inhibitors of Aβ protein production

#86
20070054881
2007-03-08

Anxiolytic agents with reduced sedative and ataxic effects

#87
20070049580
2007-03-01

ANXIOLYTIC AGENTS WITH REDUCED SEDATIVE AND ATAXIC EFFECTS

#88
20070010670
2007-01-11

Nitrogen-containing fused ring compounds and use thereof

#89
20060211679
2006-09-21

Substituted lactams as inhibitors of Abeta protein production

#90
20060148791
2006-07-06

Glutamate receptor antagonists

#91
20060142264
2006-06-29

Amide derivatives

#92
20060122169
2006-06-08

Succinoylamino benzodiazepines as inhibitors of Aβ protein production

#93
20060030553
2006-02-09

Cell adhesion inhibitors

#94
20060025407
2006-02-02

Succinoylaminobenzodiazepines as inhibitors of Aβ protein production

#95
20050261274
2005-11-24

Lactams substituted by cyclic succinates as inhibitors of Aβ protein production

#96
20050234048
2005-10-20

Glutamate receptor antagonists

#97
20050234039
2005-10-20

Substituted lactams as inhibitors of Aβ protein production

#98
20050143436
2005-06-30

Inhibitors of interleukin-1beta converting enzyme

#99
20050075327
2005-04-07

Carbamic acid alkyl ester derivatives

#100
20050059699
2005-03-17

N-acylated lipophilic amino acid derivatives

#101
20050009755
2005-01-13

Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient